Glutathione With Methimazole: What the Studies Actually Tested
Read each study in context
An increase in a glutathione measurement is a biomarker finding. To assess a liver-protection claim, check whether the study actually measured liver injury in people taking methimazole.[2–4]
| Evidence | Population and exposure | Outcome measured or reported | Question left unanswered |
|---|---|---|---|
| Human biomarker trial | 54 healthy nonsmoking adults; oral glutathione or placebo for six months | Glutathione increased in several blood and tissue measurements | Does it prevent methimazole liver injury? [2] |
| Isolated-cell experiment | Rat hepatocytes exposed to methimazole; NAC and other protective agents tested | Cell toxicity, oxidative stress, lipid peroxidation, and glutathione | Does oral glutathione protect patients? [3] |
| Mouse experiment | Methimazole injury under experimental enzyme induction or glutathione depletion; injected NAC | NAC reduced experimental injury | Is there an effective human combination regimen? [4] |
| IV product reports | Patients receiving glutathione alone or in mixtures made with a specified ingredient lot | Adverse events and elevated endotoxin prompting recalls | Is there a methimazole-specific interaction? [5] |
What the human trial can support
The randomized, double-blind trial tested oral glutathione at 250 or 1,000 mg daily in healthy adults. Several glutathione measurements increased during treatment and returned to baseline after a one-month washout. Those were research doses, not prescriptions for people taking methimazole.[2]
The trial did not test prevention of methimazole liver injury, Graves disease outcomes, or methimazole concentrations. It also cannot establish that IV or liposomal products behave like the oral preparation studied. A higher biomarker value alone does not demonstrate a clinical benefit.[2]
Why the liver-protection claim goes too far
The isolated rat-cell study and the mouse study provide experimental evidence about injury pathways and protection by NAC. NAC is a different intervention from glutathione supplementation. Neither experiment tested an oral glutathione–methimazole regimen in humans, and neither supplies a patient dose.[3,4]
The methimazole label warns about liver toxicity and agranulocytosis, a dangerous reduction in certain white blood cells. It provides no glutathione protection protocol. These sources also establish no two-hour spacing rule or safe supplement dose for concurrent use. The cited studies did not test dose separation as a way to prevent either reaction.[1–4]
Symptoms take priority over supplements
Jaundice, dark urine, itching, or right-upper-abdominal pain warrant prompt medical assessment. Do not wait for a scheduled laboratory appointment to report new liver symptoms; testing should reflect symptoms and the prescriber’s assessment.[1,6]
Fever or a severe sore throat while taking methimazole requires immediate medical contact and a blood count. Take no more methimazole until your doctor clears you to restart. Glutathione does not replace that response.[6]
IV products raise a separate question
FDA reported adverse events in at least 30 patients after IV glutathione, alone or mixed, involving a specified Medisca supplement-grade ingredient lot, 229536. Two pharmacies recalled products because of elevated endotoxin. Some patients required hospitalization. These reports do not establish a methimazole interaction or prove that glutathione itself caused the reactions.[5]
If concerned about an infusion, ask the provider for the exact product and lot. Breathing difficulty, fainting, or serious symptoms after an infusion need urgent help.[5]
Make the discussion specific
Bring your endocrinologist the product label or photograph, route, full ingredients, amount per dose, frequency, start date, and reason for use. For an infusion, include the provider and lot. Record symptoms and their timing alongside methimazole doses; this makes the exposure history usable.
Ask separately whether the supplement fits your treatment plan. These studies do not establish thyroid-hormone effects during methimazole treatment or justify extending their findings to PTU, radioactive iodine, or surgery. Get a treatment-specific plan before a procedure rather than inventing a supplement stopping interval.[2–4,6]
Frequently asked questions
Can I take glutathione with methimazole?
The cited studies do not establish the safety of concurrent use or whether glutathione changes methimazole blood levels. The methimazole label provides no combination protocol. Have your prescriber assess the exact product and your circumstances.[1–4]
Can glutathione prevent methimazole liver injury?
The human trial measured glutathione biomarkers rather than methimazole liver injury. The cell and mouse protection experiments used NAC. None tested a human glutathione–methimazole regimen for preventing liver injury. [2–4]
Should I separate methimazole and glutathione by two hours?
These sources provide no evidence-based two-hour rule. A dose gap has not been shown to prevent methimazole-related liver or blood-cell reactions.[1–4]
Which symptoms need prompt medical attention?
Promptly report jaundice, dark urine, itching, or right-upper-abdominal pain. Fever or severe sore throat requires immediate assessment and a blood count; take no more methimazole until your doctor clears restart. Seek urgent help for breathing difficulty, fainting, or serious post-infusion symptoms.[1,5,6]
Does glutathione change thyroid hormone levels during treatment?
The cited studies provide no quantitative human evidence showing how glutathione affects thyroid hormone levels during methimazole treatment. Do not use them to justify changing your methimazole dose.[2–4]
Is IV glutathione safe with methimazole?
The cited studies do not establish combination safety. FDA’s August 2026 report concerns specific IV products and endotoxin exposure. Ask the infusion provider to identify the product and ingredient lot; that report did not test a methimazole interaction. [5]
What information should I give my endocrinologist?
Provide the form, full ingredients, dose, frequency, start date, and reason for use. Include the infusion provider and lot when applicable, plus a dated symptom record and any recent treatment changes.
Can I use glutathione with other hyperthyroidism treatments?
These findings cannot establish compatibility with PTU, radioactive iodine, or surgery. Ask the treating team for a specific plan before treatment or a procedure; these sources supply no universal stopping interval.[2–4,6]
What glutathione dose has been tested with methimazole?
None of these studies establishes a human combination dose. The 250- and 1,000-mg daily doses were studied in healthy adults, not as methimazole prescriptions.[2]
Does Graves disease mean I need glutathione?
A Graves diagnosis alone does not establish a need for glutathione supplementation. Biomarker changes are not proof of a treatable deficiency or improved clinical outcomes, and the cited human trial enrolled healthy adults.[2]
References
Sources checked October 15, 2026.
- DailyMed: Methimazole tablets—U.S. prescribing information, January 2026
- Richie et al. Randomized controlled trial of oral glutathione supplementation on body stores of glutathione, 2015
- Methimazole-induced toxicity in isolated rat hepatocytes, 2013
- Methimazole-induced liver injury and protective interventions in mice, 2014
- FDA: Reminder not to use dietary supplement-grade glutathione in injectables, August 27, 2026
- American Thyroid Association: Hyperthyroidism
